In pancreatic ductal adenocarcinoma, CSCs expressed higher DNMT1 levels than non-CSCs, deletion of DNMT1 in CSCs reduced their self-renewal and tumorigenic potential [20]. This evidence concerns the gene DNMT1 and pancreatic ductal adenocarcinoma.